125 related articles for article (PubMed ID: 4032454)
1. Preparation of antibodies against the fourth complement component (C4) and development of a direct electroimmunoassay for quantification of C4d.
Folkersen J; Teisner B; Petersen NE; Sim RB; Jessen E
J Clin Lab Immunol; 1985 Mar; 16(3):163-7. PubMed ID: 4032454
[TBL] [Abstract][Full Text] [Related]
2. Classical pathway of complement activation in mammalian kidneys.
Zwirner J; Felber E; Burger R; Bitter-Suermann D; Riethmüller G; Feucht HE
Immunology; 1993 Oct; 80(2):162-7. PubMed ID: 8262545
[TBL] [Abstract][Full Text] [Related]
3. Rocket immunoelectrophoresis of C4 and C4d. A simple sensitive method for detecting complement activation in plasma.
Nitsche JF; Tucker ES; Sugimoto S; Vaughan JH; Curd JG
Am J Clin Pathol; 1981 Nov; 76(5):679-84. PubMed ID: 6794354
[TBL] [Abstract][Full Text] [Related]
4. Activation of the fourth component of complement (C4): assessment by rocket immunoelectrophoresis and correlation with the metabolism of C4.
Milgrom H; Curd JG; Kaplan RA; Müller-Eberhard HJ; Vaughan JH
J Immunol; 1980 Jun; 124(6):2780-5. PubMed ID: 7373050
[TBL] [Abstract][Full Text] [Related]
5. Immunoelectrophoretic analysis of C4 split products expressing D but not C epitopes: influence of storage, Ca2+ and Ca2+-chelating agents.
Petersen NE; Folkersen J; Teisner B; Svehag SE
Complement; 1985; 2(2-3):147-55. PubMed ID: 2417781
[TBL] [Abstract][Full Text] [Related]
6. [In-vivo activation of the 4th component of the complement system (C4) in premature and term infants with generalized bacterial infections].
Nürnberger W; Stannigel H; Müntel V; Michelmann I; Wahn V; Göbel U
Klin Padiatr; 1990; 202(3):141-6. PubMed ID: 2355716
[TBL] [Abstract][Full Text] [Related]
7. A specific assay for quantification of human C4c by use of an anti-C4c monoclonal antibody.
Pilely K; Skjoedt MO; Nielsen C; Andersen TE; Louise Aabom A; Vitved L; Koch C; Skjødt K; Palarasah Y
J Immunol Methods; 2014 Mar; 405():87-96. PubMed ID: 24472768
[TBL] [Abstract][Full Text] [Related]
8. Classical and alternative complement pathway activation in paracoccidioidomycosis.
de Messias IT; Mohren D
J Investig Allergol Clin Immunol; 1994; 4(2):91-5. PubMed ID: 7921333
[TBL] [Abstract][Full Text] [Related]
9. [The in vitro inhibitory effect of sodium selenite on complement activation].
Li B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Jun; 13(3):195-8. PubMed ID: 1652384
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of C4 antiserum and detection of complement C4 activation in plasma with crossed immunoelectrophoresis].
Hou JC; Kou MX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Dec; 7(6):473-4. PubMed ID: 2940011
[No Abstract] [Full Text] [Related]
11. Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.
Davies ET; Nasaruddin BA; Alhaq A; Senaldi G; Vergani D
J Clin Pathol; 1988 Feb; 41(2):143-7. PubMed ID: 3350977
[TBL] [Abstract][Full Text] [Related]
12. Conversion of the C4d.2 serologic allotype of murine complement component C4 to the C4d.1 allotype by site-specific mutagenesis.
Mathias P; Shreffler DC; Cooper NR; Ogata RT
J Immunol; 1990 Jan; 144(2):607-9. PubMed ID: 2295802
[TBL] [Abstract][Full Text] [Related]
13. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
Senaldi G; Makinde VA; Vergani D; Isenberg DA
Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.
Taillon-Miller PA; Shreffler DC
J Immunol; 1988 Oct; 141(7):2382-7. PubMed ID: 2459207
[TBL] [Abstract][Full Text] [Related]
15. Chido and Rogers antigenic determinant on the fourth component of human complement.
Chu VF; Marsh WL; Gigli I
J Immunol; 1982 Jan; 128(1):181-5. PubMed ID: 6172476
[TBL] [Abstract][Full Text] [Related]
16. Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway.
Wolbink GJ; Bollen J; Baars JW; ten Berge RJ; Swaak AJ; Paardekooper J; Hack CE
J Immunol Methods; 1993 Jul; 163(1):67-76. PubMed ID: 7687639
[TBL] [Abstract][Full Text] [Related]
17. Complement activation and immune complexes in juvenile rheumatoid arthritis.
Jarvis JN; Pousak T; Krenz M; Iobidze M; Taylor H
J Rheumatol; 1993 Jan; 20(1):114-7. PubMed ID: 8441140
[TBL] [Abstract][Full Text] [Related]
18. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
[TBL] [Abstract][Full Text] [Related]
19. [Aspects of the quantification of components of human complement. III. Determination of the C4 component of complement].
Votruba T; Rákosník P; Vancurík J; Hrudková M
Cesk Epidemiol Mikrobiol Imunol; 1984 Mar; 33(2):83-7. PubMed ID: 6232012
[No Abstract] [Full Text] [Related]
20. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
